As of 2024-12-15, the Relative Valuation of Outlook Therapeutics Inc (OTLK) is (89.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of Outlook Therapeutics Inc based on Relative Valuation is -6116.2%.
The range of the Relative Valuation is (82.36) - (76.40) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (82.36) - (76.40) | (89.04) |
| Upside | -5665.0% - -5262.1% | -6116.2% |
| Date | P/E |
| 2024-12-13 | -0.37 |
| 2024-12-12 | -0.39 |
| 2024-12-11 | -0.39 |
| 2024-12-10 | -0.41 |
| 2024-12-09 | -0.43 |
| 2024-12-06 | -0.38 |
| 2024-12-05 | -0.37 |
| 2024-12-04 | -0.42 |
| 2024-12-03 | -0.45 |
| 2024-12-02 | -0.51 |
| 2024-11-29 | -0.52 |
| 2024-11-27 | -0.43 |
| 2024-11-26 | -1.23 |
| 2024-11-25 | -1.24 |
| 2024-11-22 | -1.27 |
| 2024-11-21 | -1.29 |
| 2024-11-20 | -1.33 |
| 2024-11-19 | -1.32 |
| 2024-11-18 | -1.30 |
| 2024-11-15 | -1.36 |
| 2024-11-14 | -1.39 |
| 2024-11-13 | -1.50 |
| 2024-11-12 | -1.58 |
| 2024-11-11 | -1.63 |
| 2024-11-08 | -1.59 |
| 2024-11-07 | -1.68 |
| 2024-11-06 | -1.64 |
| 2024-11-05 | -1.60 |
| 2024-11-04 | -1.52 |
| 2024-11-01 | -1.52 |
| 2024-10-31 | -1.45 |
| 2024-10-30 | -1.45 |
| 2024-10-29 | -1.44 |
| 2024-10-28 | -1.45 |
| 2024-10-25 | -1.37 |
| 2024-10-24 | -1.35 |
| 2024-10-23 | -1.33 |
| 2024-10-22 | -1.39 |
| 2024-10-21 | -1.43 |
| 2024-10-18 | -1.34 |
| 2024-10-17 | -1.29 |
| 2024-10-16 | -1.31 |
| 2024-10-15 | -1.29 |
| 2024-10-14 | -1.28 |
| 2024-10-11 | -1.30 |
| 2024-10-10 | -1.24 |
| 2024-10-09 | -1.25 |
| 2024-10-08 | -1.31 |
| 2024-10-07 | -1.29 |
| 2024-10-04 | -1.32 |